Pharmaceuticals
-
Section 232 Blues: The Trump Administration’s National Security Investigation into Pharmaceuticals and Its Impact on the Research Triangle
By: Chris Beckham On April 16, the Trump Administration (Administration) initiated a national security investigation into pharmaceuticals and their ingredients under… Read More
-
Addicted to Advertising: Should the U.S. Continue to Allow Direct-to-Consumer Drug Advertising?
Grace Genereaux Whether you are watching television, scrolling on TikTok, or browsing the internet, you are likely to see one… Read More
-
Litigating Opioid Addiction as Organized Crime: An Analysis of Proximate Cause and Pharmaceutical Misrepresentation Under RICO
11 Wake Forest L. Rev. Online 93 Introduction In 2018, 128 people died every day from an opioid overdose, twenty-five… Read More